Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse

被引:45
|
作者
Zhao, Haikang [1 ]
Chang, Rui [2 ]
Che, Haijiang [3 ]
Wang, Jianbang [4 ]
Yang, Lei [1 ]
Fang, Wei [5 ]
Xia, Yi [5 ]
Li, Nan [5 ]
Ma, Quanrui [6 ]
Wang, Xuelian [5 ]
机构
[1] Xian Med Univ, Dept Neurosurg, Affiliated Hosp 2, Xian, Peoples R China
[2] Xian Xidian Grp Hosp, Dept Orthopaed, Xian, Peoples R China
[3] Xian Xidian Grp Hosp, Dept Neurosurg, Xian, Peoples R China
[4] Xian Med Univ, Affiliated Hosp 2, Dept Cardiol, Xian, Peoples R China
[5] Fourth Mil Med Univ, Dept Neurosurg, Tangdu Hosp, Xian 710038, Peoples R China
[6] Ningxia Med Univ, Dept Anat, Yinchuan, Peoples R China
关键词
Alzheimer disease; Phosphorylated tau; Calpain; Cdk5; Tau pathology; AMYLOID PRECURSOR; IMPAIRMENT; EXPRESSION; PATHOLOGY; SYSTEM; MODEL; NEURODEGENERATION;
D O I
10.1016/j.neulet.2013.06.026
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Aim to investigate phosphorylated tau expression and its pathogenic mechanism in eye of Alzheimer's disease (AD) transgenic mice. Levels of tau, phosphorylated tau and other related factors (p35/p25, Cyclin-dependent kinase 5 (Cdk5), calpain) were observed by western blot. beta-Amyloid (A beta) plaques and neuron-fibrillary tangles (NFTs) in APP/PS1 double transgenic mice were detected by immunohistochemistry. We found that hyper-expression of phosphorylated tau was detected in retina, and only a few or no expressed in optic nerve, cornea and lens of transgenic mice. Increased senile plaques (A beta) and NFTs were observed in transgenic mice accompanying with increased tau phosphorylation. The increased tau phosphorylation was associated with a significant increase in production of p35 and p25, and up-regulation of calpain. In conclusion, phosphorylated tau level was highly expressed in retina of AD transgenic mice. The pathogenic mechanism of AD was triggered by accelerating tau pathology via calpain-mediated tau hyper-phosphorylation in retina of an AD mice model. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:12 / 16
页数:5
相关论文
共 50 条
  • [21] p73 haploinsufficiency causes tau hyperphosphorylation and tau kinase dysregulation in mouse models of aging and Alzheimer's disease
    Cancino, Gonzalo I.
    Miller, Freda D.
    Kaplan, David R.
    [J]. NEUROBIOLOGY OF AGING, 2013, 34 (02) : 387 - 399
  • [22] Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease
    Vaisid, Tali
    Kosower, Nechama. S.
    Katzav, Aviva
    Chapman, Joab
    Barnoy, Sivia
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2007, 51 (6-7) : 391 - 397
  • [23] Transgenic Mouse Models with Tau Pathology to Test Therapeutic Agents for Alzheimer's Disease
    Hernandez, Felix
    Lim, Filip
    Lucas, Jose J.
    Perez-Martin, Concepcion
    Moreno, Franscisco
    Avila, Jesus
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2002, 2 (01) : 51 - 58
  • [24] Tau transgenic mouse models and their relevance to progressive supranuclear palsy and Alzheimer's disease
    Lewis, J
    [J]. MOVEMENT DISORDERS, 2002, 17 (06) : 1404 - 1404
  • [25] Tau expression in transgenic mouse models of amyotrophic lateral sclerosis and Alzheimer's disease
    Kuzma, M.
    Kazmierczak, B.
    Usarek, E.
    Gajewska, B.
    Muench, C.
    Ludolph, A. C.
    Baranczyk-Kuzma, A.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 121 - 121
  • [26] A mini review: Tau transgenic mouse models and olfactory dysfunction in Alzheimer's Disease
    Yang HU
    Wen-ting DING
    Xiao-nan ZHU
    Xue-lan WANG
    [J]. 中国应用生理学杂志, 2015, 31 (06) : 481 - 490
  • [27] Tau protein and Alzheimer's disease
    Kosik, K. S.
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1990, 2 (01) : 101 - 104
  • [28] Tau Protein in Alzheimer's Disease
    Maccioni, Ricardo B.
    [J]. CURRENT ALZHEIMER RESEARCH, 2011, 8 (06) : 607 - 607
  • [29] Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease
    Gratuze, Maud
    Noel, Anastasia
    Julien, Carl
    Cisbani, Giulia
    Milot-Rousseau, Philippe
    Morin, Francoise
    Dickler, Maya
    Goupil, Claudia
    Bezeau, Francois
    Poitras, Isabelle
    Bissonnette, Stephanie
    Whittington, Robert A.
    Hebert, Sebastien S.
    Cicchetti, Francesca
    Parker, J. Alex
    Samadi, Pershia
    Planel, Emmanuel
    [J]. HUMAN MOLECULAR GENETICS, 2015, 24 (01) : 86 - 99
  • [30] Development of inhibitors of pathological tau hyperphosphorylation for a disease modifying approach to Alzheimer's disease
    Sahagun, H
    Hübinger, G
    Klafki, H
    Gordon, S
    Ferrand, S
    Mülbacher, S
    Müller, S
    Seneci, P
    Monse, B
    Fröhner, W
    Casiraghi, L
    Thillaye du Boullay, O
    Braxmeier, T
    LeCorre, S
    Dirscherl, L
    Jolivalt, C
    Lahu, G
    Sobek-Klocke, I
    Plesnila, N
    Hutton, M
    Roder, H
    [J]. NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2005, 2005, : 71 - 76